Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M62,166Revenue (TTM) $M20,556Net Margin (%)11.1Altman Z-Score3.7
Enterprise Value $M66,760EPS (TTM) $1.5Operating Margin %14.0Piotroski F-Score5
P/E(ttm)28.0Beneish M-Score-2.4Pre-tax Margin (%)11.0Higher ROA y-yN
Price/Book3.010-y EBITDA Growth Rate %0.2Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %-16.2Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow37.5y-y EBITDA Growth Rate %-16.5ROA % (ttm)5.5Higher Current Ratio y-yN
Dividend Yield %2.4PEG--ROE % (ttm)10.7Less Shares Outstanding y-yY
Payout Ratio %78.0Shares Outstanding M1,470ROIC % (ttm)69.8Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTRobert Olstein 2016-06-30 Sold Out -1.23%$36.95 - $44.08
($39.84)
$ 42.296%Sold Out0
ABTFirst Eagle Investment 2016-06-30 Reduce-0.48%$36.95 - $44.08
($39.84)
$ 42.296%Reduce -60.38%2,974,455
ABTVanguard Health Care Fund 2016-06-30 Add0.38%$36.95 - $44.08
($39.84)
$ 42.296%Add 74.36%10,508,900
ABTJoel Greenblatt 2016-06-30 Reduce-0.34%$36.95 - $44.08
($39.84)
$ 42.296%Reduce -84.91%130,054
ABTRichard Pzena 2016-06-30 Add0.17%$36.95 - $44.08
($39.84)
$ 42.296%Add 14.76%5,327,448
ABTGeorge Soros 2016-06-30 Reduce-0.11%$36.95 - $44.08
($39.84)
$ 42.296%Reduce -21.47%329,181
ABTKen Fisher 2016-06-30 Reduce$36.95 - $44.08
($39.84)
$ 42.296%Reduce -19.63%12,387
ABTMario Gabelli 2016-06-30 Reduce$36.95 - $44.08
($39.84)
$ 42.296%Reduce -0.07%13,685
ABTJoel Greenblatt 2016-03-31 Add0.35%$36.34 - $44.91
($39.68)
$ 42.297%Add 771.99%861,862
ABTGeorge Soros 2016-03-31 Reduce-0.2%$36.34 - $44.91
($39.68)
$ 42.297%Reduce -36.89%419,181
ABTRobert Olstein 2016-03-31 Add0.11%$36.34 - $44.91
($39.68)
$ 42.297%Add 9.45%220,000
ABTFirst Eagle Investment 2016-03-31 Add0.09%$36.34 - $44.91
($39.68)
$ 42.297%Add 12.53%7,507,515
ABTRichard Pzena 2016-03-31 Reduce-0.06%$36.34 - $44.91
($39.68)
$ 42.297%Reduce -4.50%4,642,170
ABTMario Gabelli 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 42.297%Reduce -22.30%13,695
ABTDodge & Cox 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 42.297%Reduce -3.30%29,268
ABTKen Fisher 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 42.297%Reduce -10.84%15,413
ABTJoel Greenblatt 2015-12-31 Reduce-0.53%$39.89 - $46.05
($44.24)
$ 42.29-4%Reduce -93.21%98,838
ABTRobert Olstein 2015-12-31 Add0.15%$39.89 - $46.05
($44.24)
$ 42.29-4%Add 14.20%201,000
ABTVanguard Health Care Fund 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 42.29-4%Reduce -13.14%6,027,260
ABTRichard Pzena 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 42.29-4%Reduce -6.31%4,861,129
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Salvadori Daniel Gesua SiveSenior Vice President 2016-09-26Sell815$41.711.39view
Fussell Stephen RExecutive Vice President 2016-07-28Sell41,500$45-6.02view
Warmuth Michael JExecutive Vice President 2016-07-26Sell26,800$43.49-2.76view
Funck Robert EVice President, Controller 2016-07-25Sell26,800$43.08-1.83view
WHITE MILES DChairman and CEO 2016-07-25Buy17,933$43.34-2.42view
WHITE MILES DChairman and CEO 2016-07-25Buy176,804$43.26-2.24view
WHITE MILES DChairman and CEO 2016-07-25Buy112,953$43.34-2.42view
WHITE MILES DChairman and CEO 2016-07-25Buy181,263$43.19-2.08view
WHITE MILES DChairman and CEO 2016-07-25Buy242,547$43.18-2.06view
ALLEN HUBERT LExecutive Vice President 2016-06-28Sell3,400$37.1413.87view

Quarterly/Annual Reports about ABT:

News about ABT:

Articles On GuruFocus.com
Abbott Receives FDA Approval for Freestyle Libre Sep 30 2016 
J&J Finally Returning to Its Roots in Diversity? Sep 26 2016 
AbbVie Joins BioArctic in Fight Against Parkinson’s Disease Sep 20 2016 
Abbott Method for Assessing Red Blood Cells Receives Patent Sep 19 2016 
Medical Companies Offer Good Value Opportunities Sep 16 2016 
John Rogers Comments on Abbott Laboratories Aug 18 2016 
John Rogers' Ariel Focus Fund 2nd Quarter Commentary Aug 18 2016 
KEELEY Mid Cap Dividend Value Fund 2nd Quarter Commentary Aug 04 2016 
Weekly CEO Buys: Abbott Laboratories, GE, OPKO Health Jul 31 2016 
Becton Dickinson: 19% EPS Growth With Good Dividends Jun 26 2016 

More From Other Websites
The Smart Money Loves These Dividend Aristocrats: Wal-Mart, Chevron, More Oct 01 2016
Abbott Receives FDA Approval for Freestyle Libre Sep 30 2016
Medical Device ETF Near Highs As Products, Equipment Groups Outperform Sep 30 2016
7 Healthcare Stocks in Focus on World Heart Day Sep 29 2016
Will Abbott (ABT) Stock Be Helped By FDA Approval of Glucose Monitoring System? Sep 28 2016
Mediation Talks Between Abbott and Alere Collapse Sep 28 2016
Jazz Pharma Closes Enrollment in OSA Drug Phase III Trial Sep 28 2016
Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, a Revolutionary Diabetes Sensing... Sep 28 2016
J&J Finally Returning to Its Roots in Diversity? Sep 26 2016
AbbVie (ABBV) HCV Combination Drug Positive in Phase IIIb Sep 26 2016
The Rationale behind Johnson & Johnson’s Acquisition of Abbott Medical Optics Sep 23 2016
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO Sep 23 2016
Disease-related malnutrition costs U.S. $15.5 bln annually - study Sep 21 2016
Malnutrition Adds $15.5 Billion Annually to Direct U.S. Medical Costs Sep 21 2016
The Zacks Analyst Blog Highlights: Abbott Labs, Comcast, Goldman Sachs, Microsoft and Philip Morris Sep 21 2016
Abbott Hosts Conference Call for Third-Quarter Earnings Sep 21 2016
Top Research Reports for Goldman Sachs, Comcast & Abbott Labs Sep 20 2016
[$$] Abbott's Deal With JNJ Is Good Strategy Sep 20 2016
Fueling Performance with Fat: EAS® Launches First Ketogenic Meal Replacement For Athletes Sep 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)